Authors


Carolyn Colwell

Latest:

Clues Found to Long-Term HIV Suppression

South African child with HIV reaches 8-plus year survival after only 40 weeks of antiretroviral therapy in infancy.



Pallavi Rane, PhD

Latest:

Variation in the Coverage of Disease-Modifying Multiple Sclerosis Drugs Among US Payers

An examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.


CEO, National Pharmaceutical Council

Latest:

Evidence: Vital but Seldom Used Consistently by Payers

Peer-reviewed research conducted by the National Pharmaceutical Council (NPC) and the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center over the past 2 years sheds some light on what’s behind discrepancies in coverage decisions from one insurer to the next.


Lauren Santye, Assistant Editor

Latest:

What Advice Would You Give to Patients?

Cancer patient Beth Wallace provides advice to patients with leiomyosarcoma, as well as to women with cancer in general.


Emily Bilas, PharmD

Latest:

Good Intentions: Writing the Letter of Intent

So, the initial meet and greet at Mid-Year went well. You have selected the 'perfect' program. Now, it is time to declare that intention in writing.



David M. Cook, MD

Latest:

Growth Hormone Therapy Guidelines: Clinical and Managed Care Perspectives

Current treatment guidelines utilized by healthcare provider organizations and managed care organization insurance coverage policies for growth hormone therapy are reviewed.



Angelica Welch

Latest:

Oncology Biosimilars Bring Hope to Patients with Cancer

Biosimilars for rituximab, trastuzumab, and bevacizumab are currently approved for use in the European Union.



Silas Inman

Latest:

Bispecifics, CAR T Cells Among Most Exciting Recent Advances in Hematologic Malignancies

Expert notes significant advances in the treatment of multiple myeloma, large B cell lymphomas, and acute myeloid leukemia, during a presentation at HOPA 2023 Annual Conference.



Abby Christopher

Latest:

ROUNDTABLE DISCUSSION: "THE FUTURE OF PHARMACY"

Ms. Christopher is a freelance writer based in Portland, Ore.


Dr. Christina Tarantola, PharmD, CHC, CHt

Latest:

Utilizing the Stages of Change to Motivate Patients

How can you engage patients to adapt healthy behaviors and be adherent? Motivational Interviewing may be the missing piece.


Stephanie LaPointe, PharmD, CSPO, FMPA

Latest:

Precision Medicine and the Pharmacist’s Role as a Trusted Counselor in Specialty Pharmacy

The placement of clinical pharmacists at the nexus of functional pharmacogenomics and in specialty pharmacy care makes good sense.


By Stephen F. Eckel, PharmD, MHA, BCPS, FASHP, FAPhA

Latest:

Making the Most of the ASHP Midyear

The editor of the Pharmacy Times Health-System Edition offers pointers on getting as much as you can out of the 2013 ASHP Midyear Clinical Meeting.


Jerry Meece, RPh, FACA, CDE

Latest:

Overcoming Barriers to Insulin Therapy

Pharmacists have an important role to play in dispelling myths about the use of insulin in effectively treating diabetes.



Nirmal K. Ghuman, PharmD, MPH

Latest:

Trends in Medication Utilization and the Cost of Treatment for Gout

With new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.


Dorothy Maziarz, PharmD

Latest:

Community Pharmacist Shortage: Fact or Fiction?

What is being done to address current and projected shortages of community pharmacists?


Sarah Tobin, PharmD Candidate

Latest:

Advanced Pharmacy Practice Rotation Experience During a Global Pandemic

COVID-19 has not stolen my final year of pharmacy school from me, but rather, has given me once in lifetime learning opportunities unique to this time in my life and in the world.



Jay Visaria, PhD, MPH

Latest:

Specialty Pharmacy Improves Adherence to Imatinib

The authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.


Peggy Salvatore, MBA

Latest:

Exploring the Versatility of Azelaic Acid in Facial Acne, Truncal Acne, Photoaging, and Melasma

Continuing education activity featured in the March 2018 edition of Pharmacy Times.


Alexis Smith, PharmD Candidate

Latest:

Neuropathic Pain: A Glimpse Inside the Unabating Affliction

Originating from damage within nerve cells themselves, neuropathic pain is often complex, with many treatment challenges.


T. Joseph Mattingly II, Juita-Elena (Wie) Yusuf, MBA, PhD

Latest:

Turning that Great Idea into a Thriving Business

Do you have an entrepreneurial idea that could be commercialized? This article describes steps to take to develop your business plan.


O’Mally Monahan

Latest:

Driving Affordability, Patient Experience Across Practice Settings

More than 25% of US patients have not filled a prescription or have reduced their prescribed dose because of high costs.


Sethu Reddy, MD, MBA

Latest:

Patient Understanding and Improved Adherence

Merck's Adherence Estimator survey can help health care professionals counsel patients more effectively.


Brandon Samson, PharmD, MPW

Latest:

Lessons Learned: How Health-System Pharmacy Technicians Are Tackling COVID-19

The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.